LONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator.
In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.”
AstraZeneca’s COVID-19 vaccine was first given the nod by the EMA in January 2021. Within weeks, however, concerns grew about the vaccine’s safety, when dozens of countries suspended the vaccine’s use after unusual but rare blood clots were detected in a small number of immunized people. The EU regulator concluded AstraZeneca’s shot didn’t raise the overall risk of clots, but doubts remained.
Partial results from its first major trial — which Britain used to authorize the vaccine — were clouded by a manufacturing mistake that researchers didn’t immediately acknowledge. Insufficient data about how well the vaccine protected older people led some countries to initially restrict its use to younger populations before reversing course.
Related articles:
Related suggestion:
Judges sceptical of Trump's immunity claim in election subversion caseEaster weekend: What's open, what's not and when you have to pay a surchargeFree trade deal with India challenging but not impossibleFunding needed to take show aimed at disabled communities around AotearoaWatch: Peru policeman dressed as bear pounces on Valentine’s DayWaitangi 2024: Thousands stand in unity to challenge government on Treaty principlesAustralian town of Marble Bar clocks 26 consecutive days over 43 degrees CelsiusFree trade deal with India challenging but not impossibleGrammys 2024: Photos from the 66th annual awardsChristchurch man jailed for 14 years over role in US porn videos
3.1806s , 6491.109375 kb
Copyright © 2024 Powered by AstraZeneca pulls COVID vaccine from European market ,Planet Panorama news portal